Press Releases

May 24th, 2022

Adult-use cannabis market share increased three positions to 13th in April 2022 vs 16th in December 2021([1]) 53% increase in adult-use market share to 2.5% in April 2022 vs December 2021([2]), representing the 5th highest growth rate among the top 40 Canadian LPs Spring & Summer launch of 12 OCS and 8 AGLC SKUs builds […]

May 12th, 2022

Transforms the company’s balance sheet with an equity financing to fund growth and a favourable resolution to amend the key commercial terms of the Convertible Debentures Provides $11.6 million[1] in additional liquidity to fund working capital and growth initiatives and finance the company attaining break-even Adjusted EBITDA profitability in 2022[2] Augments the refinancing profile extending […]

April 28th, 2022

Holders representing approximately 62% of total Debentures extend Forbearance Period until May 12, 2022 to allow negotiations to continue   TORONTO – April 27, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on […]

April 11th, 2022

Holders representing approximately 62% of total Debentures extend Forbearance Period until April 26, 2022 to allow negotiations to continue   TORONTO – April 11, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on […]

April 7th, 2022

$4.4 million annualized cost reductions being implemented in addition to $2.3 million announced in February 2022 Grimsby, Ontario cultivation organization realigned to support anticipated growth in product throughput Organizational realignment in the medical business to fully integrate the sales channels Core corporate shared services consolidated and leveraged across all sales channels Company operating leverage in […]

March 29th, 2022

Holders representing approximately 62% of total Debentures extend Forbearance Period until April 11, 2022 to allow negotiations to continue   TORONTO – March 29, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on […]

March 25th, 2022

Reached new record market share overall adult use market share of 2.06% in February 2022, advancing 33% from 1.54% in November 2021(1) Continued ascent in overall market share rankings, up two more notches to 13th in February 2022 from 15th in November 2021 On the pathway towards a top 10 market share position by the […]

March 16th, 2022

Holders representing approximately 62% of total Debentures extend Forbearance Period until March 28, 2022 to allow negotiations to continue   TORONTO – March 16, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on […]

March 1st, 2022

Holders representing approximately 62% of total Debentures extend Forbearance Period until March 14, 2022 to allow negotiations to continue   TORONTO – March 1, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on […]

February 15th, 2022

Transforming business towards a branded cannabis provider, with branded revenue representing 80% of total net revenue in 2021 compared to 33% in 2020  96% increase in branded cannabis net revenue to $28.7 million in 2021 from $14.6 million in 2020   396% increase in adult-use net revenue to $16.0 million in 2021 from $3.2 million in […]

February 8th, 2022

TORONTO – February 8, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce results from its three and 12-month periods ending December 31, 2021 on February 14, 2022. The Company will also host its earnings conference call on February 15 at 9:30 a.m. EST. The call will be […]

February 7th, 2022

TORONTO –February 7, 2022  – The Board of Directors of Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) today announced that CEO Geoffrey Benic will leave the Company, effective February 7, 2022.  To succeed Benic, the Board named Tricia Symmes, previously the Company’s Chief Commercial Officer (CCO), as the Company’s new […]

February 1st, 2022

Entered into Forbearance Agreement with Holders representing 58% of total Debentures Negotiating a potential transaction to amend the Convertible Debt terms for all debenture holders   TORONTO –  February 1, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured […]

January 4th, 2022

TORONTO –  January 4, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 (the “Convertible Debt”). The Company has initiated negotiations with debenture holders […]

December 29th, 2021

Credit Facility provides the Company with liquidity to fund operations and organic growth initiatives Two-year term provides additional financial flexibility TORONTO – December 29, 2021 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the closing of a credit facility of up to $19 million (the “Credit […]